Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign

Dermatology

Volumn 207, Issue 3, 2003, Pages 329-330

  Banka, Nusrat ^a   Aljurf, Mahmoud ^a   Hamadah, Issam ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; DRUG ERUPTION; DRUG TOLERABILITY; EDEMA; ERYTHEMA; EXFOLIATIVE DERMATITIS; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; PRURITUS; RASH; SHIVERING;

ADULT; BIOPSY, NEEDLE; DERMATITIS, EXFOLIATIVE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, CHRONIC; MALE; PIPERAZINES; PYRIMIDINES; RISK ASSESSMENT; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX;

EID: 0142227847     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073102     Document Type: Article

References (5)

1. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno Jones S, Sawyers CL: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037.
2. Saurat JH: Papuloerythroderma: Disease or Pattern? (editorial). Dermatology 1993;186:163.
3. Brouard M, Prins C, Mach-Pascual S, Saurat JH: Acute generalised exanthematous pustulosis associated with STI-571 in a patient with chronic myeloid leukemia. Dermatology 2001;203:57-59.
4. Lim DS, Muir J: Oral lichenoid reaction to imatinib (STI 571, Gleevec). Dermatology 2002;205:169-171.
5. Konstantopoulos K, Papadogianni, Dimopoulou M, Kourelis C, Meletis J: Pityriasis rosea associated with imatinib (STI 571, Gleevec). Dermatology 2002;205:172-173.